NASDAQ:FBLG | Free Cash Flow | FibroBiologics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2022-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$4.36M$0.00-$4.36M
2025-12-31-$3.16M$0.00-$3.16M
2025-03-31-$5.28M$43,000.00-$5.32M
2024-12-31-$3.07M$99,000.00-$3.17M
2024-03-31-$4.28M$8,000.00-$4.28M
2023-12-31-$1.6M$2,000.00-$1.6M
2023-03-31-$2.04M$56,000.00-$2.09M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$16.39M$262,000.00-$16.66M
2024-12-31-$11.9M$184,000.00-$12.09M
2023-12-31-$6.4M$495,000.00-$6.9M
2022-12-31-$4.07M